MetaADEDB 2.0 @ LMMD
pramlintide
(NRKVKVQDUCJPIZ-MKAGXXMWSA-N)
Structure
SMILES
NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc1ccc(cc1)O)[C@H](O)C)CC(=O)N)CO)C(C)C)CC(=O)N)[C@H](O)C)CC(C)C)[C@H](CC)C)Cc1ccccc1)CC(=O)N)CC(=O)N)CO)CO)Cc1[nH]cnc1)C(C)C)CC(C)C)Cc1ccccc1)CC(=O)N)C)CC(C)C)CCCNC(=N)N)CCC(=O)N)[C@H](O)C)C)CS)[C@H](O)C)C)[C@H](O)C)CC(=O)N)CS)N
Molecular Formula:
C171H269N51O53S2
Molecular Weight:
3951.410
Log P:
-3.4532
Hydrogen Bond Acceptor:
105
Hydrogen Bond Donor:
58
TPSA:
1768.24
CAS Number(s):
N/A
Synonym(s)
1.
pramlintide
2.
AC 0137
3.
AC 137
4.
LYS-CYS-ASN-THR-ALA-THR-CYS-ALA-THR-GLN-ARG-LEU-ALA-ASN-PHE-LEU-VAL-HIS-SER-SER-ASN-ASN-PHE-GLY-PRO-ILE-LEU-PRO-PRO-THR-ASN-VAL-GLY-SER-ASN-THR-TYR-NH2
5.
Symlin
6.
Tripro-Amylin
7.
pramlintide acetate
External Link(s)
MeSHC105254
PubChem Compound16132446
132274288
Therapeutic Target DatabaseD0C4AM
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1NauseaFAERS: 71SIDER
US FAERS
2Injection site painFAERS: 70US FAERS
3Blood glucose increasedFAERS: 53US FAERS
4Weight decreasedFAERS: 49US FAERS
5Medication ErrorFAERS: 32US FAERS
6Injection site bruisingFAERS: 31US FAERS
7Drug ineffectiveFAERS: 21US FAERS
8Incorrect dose administeredFAERS: 18US FAERS
9VomitingFAERS: 16SIDER
US FAERS
10FatigueFAERS: 14SIDER
US FAERS
11Blood glucose decreasedFAERS: 13US FAERS
12HeadacheFAERS: 11SIDER
US FAERS
13Injection site irritationFAERS: 11US FAERS
14Drug prescribing errorFAERS: 10US FAERS
15Blood glucose abnormalFAERS: 9US FAERS
16UrticariaFAERS: 9US FAERS
17Feeling abnormalFAERS: 8US FAERS
18Injection site erythemaFAERS: 8US FAERS
19MalaiseFAERS: 8US FAERS
20Product quality issueFAERS: 8US FAERS
21Circumstance or information capable of leading to medication errorFAERS: 6US FAERS
22Drug ineffective for unapproved indicationFAERS: 6US FAERS
23Therapeutic response unexpectedFAERS: 6US FAERS
24DizzinessFAERS: 5SIDER
US FAERS
25Drug dose omissionFAERS: 5US FAERS
26Intentional product misuseFAERS: 5US FAERS
27LethargyFAERS: 5US FAERS
28Pharmaceutical product complaintFAERS: 5US FAERS
29AnorexiaFAERS: 4SIDER
US FAERS
30Blood glucose fluctuationFAERS: 4US FAERS
31ConstipationFAERS: 4US FAERS
32Injection site pruritusFAERS: 4US FAERS
33Pancreatic carcinomaFAERS: 4US FAERS
34Abdominal PainFAERS: 3SIDER
US FAERS
35ArthralgiaFAERS: 3SIDER
US FAERS
36AstheniaFAERS: 3SIDER
US FAERS
37Chest PainFAERS: 3US FAERS
38DehydrationFAERS: 3US FAERS
39Drug administration errorFAERS: 3US FAERS
40Drug dispensing errorFAERS: 3US FAERS
41DyspepsiaFAERS: 3US FAERS
42Early satietyFAERS: 3US FAERS
43NasopharyngitisFAERS: 3US FAERS
44NervousnessFAERS: 3US FAERS
45OverdoseFAERS: 3US FAERS
46PancreatitisFAERS: 3SIDER
US FAERS
47PancytopeniaFAERS: 3US FAERS
48Portal HypertensionFAERS: 3US FAERS
49Product use issueFAERS: 3US FAERS
50SomnolenceFAERS: 3US FAERS
51SplenomegalyFAERS: 3US FAERS
52jaundiceFAERS: 3US FAERS
53Abdominal discomfortFAERS: 2US FAERS
54Adverse eventFAERS: 2US FAERS
55Blood pH decreasedFAERS: 2US FAERS
56Carbon dioxide decreasedFAERS: 2US FAERS
57CellulitisFAERS: 2US FAERS
58Chest discomfortFAERS: 2US FAERS
59ChillsFAERS: 2US FAERS
60Depressed moodFAERS: 2US FAERS
61Diabetic KetoacidosisFAERS: 2US FAERS
62DysgeusiaFAERS: 2US FAERS
63FlatulenceFAERS: 2US FAERS
64HypersensitivityFAERS: 2SIDER
US FAERS
65InfluenzaFAERS: 2US FAERS
66Injection site extravasationFAERS: 2US FAERS
67Injection site urticariaFAERS: 2US FAERS
68Memory impairmentFAERS: 2US FAERS
69MyalgiaFAERS: 2US FAERS
70Myocardial InfarctionFAERS: 2US FAERS
71NephrolithiasisFAERS: 2US FAERS
72No adverse effectFAERS: 2US FAERS
73Pharyngolaryngeal PainFAERS: 2US FAERS
74PruritusFAERS: 2US FAERS
75SwellingFAERS: 2US FAERS
76TremorFAERS: 2US FAERS
77VertigoFAERS: 2US FAERS
78Visual ImpairmentFAERS: 2US FAERS
79Accidental exposureFAERS: 1US FAERS
80Accidental needle stickFAERS: 1US FAERS
81Accidental overdoseFAERS: 1US FAERS
82Alcohol IntoleranceFAERS: 1US FAERS
83Alcohol poisoningFAERS: 1US FAERS
84AlopeciaFAERS: 1US FAERS
85AneurysmFAERS: 1US FAERS
86AnxietyFAERS: 1US FAERS
87AphagiaFAERS: 1US FAERS
88ArthritisFAERS: 1US FAERS
89Auricular swellingFAERS: 1US FAERS
90Back PainFAERS: 1US FAERS
91Biliary cirrhosisFAERS: 1US FAERS
92Bipolar DisorderFAERS: 1US FAERS
93Blood calcium abnormalFAERS: 1US FAERS
94Blood sodium decreasedFAERS: 1US FAERS
95Blood triglycerides decreasedFAERS: 1US FAERS
96Blood triglycerides increasedFAERS: 1US FAERS
97Bone painFAERS: 1US FAERS
98CataractFAERS: 1US FAERS
99Choking sensationFAERS: 1US FAERS
100CholecystitisFAERS: 1US FAERS
101CholelithiasisFAERS: 1US FAERS
102Cold sweatFAERS: 1US FAERS
103Corrective lens userFAERS: 1US FAERS
104CystFAERS: 1US FAERS
105Device malfunctionFAERS: 1US FAERS
106DiscomfortFAERS: 1US FAERS
107Disease complicationFAERS: 1US FAERS
108DisorientationFAERS: 1US FAERS
109Drug administered at inappropriate siteFAERS: 1US FAERS
110Drug exposure during pregnancyFAERS: 1US FAERS
111EpistaxisFAERS: 1US FAERS
112EructationFAERS: 1US FAERS
113ErythemaFAERS: 1US FAERS
114Eye inflammationFAERS: 1US FAERS
115Food aversionFAERS: 1US FAERS
116Foreign body traumaFAERS: 1US FAERS
117Full blood count decreasedFAERS: 1US FAERS
118GastritisFAERS: 1US FAERS
119General physical health deteriorationFAERS: 1US FAERS
120HyperchlorhydriaFAERS: 1US FAERS
121Hypoaesthesia facialFAERS: 1US FAERS
122Incorrect drug dosage form administeredFAERS: 1US FAERS
123InfectionFAERS: 1US FAERS
124Injection Site ReactionFAERS: 1SIDER
US FAERS
125Injection site discomfortFAERS: 1US FAERS
126Injection site noduleFAERS: 1US FAERS
127Injection site pustuleFAERS: 1US FAERS
128Injection site vesiclesFAERS: 1US FAERS
129Injection site warmthFAERS: 1US FAERS
130Lipase increasedFAERS: 1US FAERS
131Malignant neoplasm progressionFAERS: 1US FAERS
132MastoiditisFAERS: 1US FAERS
133Medical device complicationFAERS: 1US FAERS
134MenorrhagiaFAERS: 1US FAERS
135Mental impairmentFAERS: 1US FAERS
136Migraine with AuraFAERS: 1US FAERS
137Muscle abscessFAERS: 1US FAERS
138Oropharyngeal painFAERS: 1US FAERS
139Pancreatic NeoplasmFAERS: 1US FAERS
140Personality ChangeFAERS: 1US FAERS
141Pharyngolaryngeal discomfortFAERS: 1US FAERS
142PneumoniaFAERS: 1US FAERS
143Poor quality sleepFAERS: 1US FAERS
144PresyncopeFAERS: 1US FAERS
145Procedural vomitingFAERS: 1US FAERS
146Rectal dischargeFAERS: 1US FAERS
147Renal painFAERS: 1US FAERS
148RetchingFAERS: 1US FAERS
149Single functional kidneyFAERS: 1US FAERS
150SinusitisFAERS: 1US FAERS
151Skin lacerationFAERS: 1US FAERS
152ThrombosisFAERS: 1US FAERS
153Unevaluable eventFAERS: 1US FAERS
154Visual disturbanceFAERS: 1US FAERS
155Wrong drug administeredFAERS: 1US FAERS
156Wrong technique in device usage processFAERS: 1US FAERS
157Wrong technique in drug usage processFAERS: 1US FAERS
158gallbladder neoplasmFAERS: 1US FAERS
159Gastrointestinal PainSIDER
160Inflicted injurySIDER
161Musculoskeletal discomfortSIDER
162PharyngitisSIDER
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120235

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.